We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+7.44%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$25.3B
AUM Growth
+$2.28B
(+9.9%)
Cap. Flow
+$944M
Cap. Flow
% of AUM
3.73%
Top 10 Holdings %
Top 10 Hldgs %
31.14%
Holding
1,538
New
18
Increased
913
Reduced
179
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$115M |
| 2 |
Boston Scientific
BSX
|
+$76.1M |
| 3 |
AptarGroup
ATR
|
+$51.5M |
| 4 |
Halozyme
HALO
|
+$49.1M |
| 5 |
Fluence Energy
FLNC
|
+$37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$53.5M |
| 2 |
Broadcom
AVGO
|
+$37.8M |
| 3 |
WillScot Mobile Mini Holdings
WSC
|
+$37.5M |
| 4 |
TE Connectivity
TEL
|
+$26.7M |
| 5 |
NVIDIA
NVDA
|
+$23.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.77% |
| 2 | Healthcare | 19.94% |
| 3 | Financials | 10.69% |
| 4 | Industrials | 8.65% |
| 5 | Communication Services | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Genworth Financial
GNW
$3.76B
| $519K | ﹤0.01% |
75,790
| – | – |
|
1227
Quaker Houghton
KWR
$2.95B
| $519K | ﹤0.01% |
3,079
+400
| +15% | +$67.6K |
|
1228
Artisan Partners
APAM
$2.98B
| $517K | ﹤0.01% |
11,923
| – | – |
|
1229
Apogee Therapeutics
APGE
$10.2B
| $517K | ﹤0.01% |
8,800
+1,800
| +26% | +$86.2K |
|
1230
Cimpress
CMPR
$2.35B
| $516K | ﹤0.01% |
6,296
+800
| +15% | +$70.9K |
|
1231
The Bancorp
TBBK
$2.83B
| $514K | ﹤0.01% |
9,600
| – | – |
|
1232
Harmonic Inc
HLIT
$1.39B
| $513K | ﹤0.01% |
35,200
| – | – |
|
1233
Joby Aviation
JOBY
$8B
| $512K | ﹤0.01% |
101,700
+24,500
| +32% | +$133K |
|
1234
Simmons First National
SFNC
$3.46B
| $512K | ﹤0.01% |
23,760
| – | – |
|
|
VRE
1235
DELISTED
Veris Residential
VRE
| $508K | ﹤0.01% |
28,457
+4,500
| +19% | +$74.2K |
|
|
DVAX
1236
DELISTED
Dynavax Technologies
DVAX
| $506K | ﹤0.01% |
45,400
| – | – |
|
1237
Tennant Co
TNC
$1.16B
| $506K | ﹤0.01% |
5,265
+500
| +10% | +$48.8K |
|
|
SAFE
1238
Safehold
SAFE
$1.1B
| $505K | ﹤0.01% |
19,243
+1,600
| +9% | +$37.8K |
|
1239
NCR Voyix
VYX
$1.13B
| $505K | ﹤0.01% |
37,204
+8,200
| +28% | +$110K |
|
1240
Under Armour Class C
UA
$2.26B
| $504K | ﹤0.01% |
60,300
+20,600
| +52% | +$148K |
|
1241
Advance Auto Parts
AAP
$3.4B
| $499K | ﹤0.01% |
12,800
| – | – |
|
1242
Freshworks
FRSH
$3.27B
| $498K | ﹤0.01% |
43,400
+11,200
| +35% | +$134K |
|
|
JBGS
1243
JBG SMITH
JBGS
$695M
| $498K | ﹤0.01% |
28,500
+2,900
| +11% | +$49.2K |
|
1244
Park National Corp
PRK
$3.74B
| $498K | ﹤0.01% |
2,965
| – | – |
|
|
AIV
1245
Aimco
AIV
$378M
| $497K | ﹤0.01% |
54,948
+13,900
| +34% | +$124K |
|
1246
AtriCure
ATRC
$2.21B
| $496K | ﹤0.01% |
17,700
+3,000
| +20% | +$73.9K |
|
1247
Riot Platforms
RIOT
$7.36B
| $496K | ﹤0.01% |
66,800
+17,200
| +35% | +$149K |
|
1248
Hims & Hers Health
HIMS
$6.75B
| $494K | ﹤0.01% |
26,800
| – | – |
|
|
THS
1249
DELISTED
Treehouse Foods
THS
| $492K | ﹤0.01% |
11,709
| – | – |
|
1250
Astrana Health
ASTH
$1.83B
| $492K | ﹤0.01% |
8,500
+1,200
| +16% | +$59K |
|
Similar funds
VIA
GAM
Handelsbanken Fonder's Q3 2024 Portfolio in Review
As of Q3 2024, Handelsbanken Fonder held 1,538 positions worth $25.3B, up 9.9% from $23B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Handelsbanken Fonder deployed $944M of net new capital in Q3 2024, opening 18 new positions and adding to 913 existing holdings. Its largest new stake was Edison International: 24,542 shares worth $2.14M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Edwards Lifesciences, an estimated $53.5M trimmed.
- Handelsbanken Fonder's largest Q3 2024 buy was Edison International: 24,542 shares worth $2.14M.
- Handelsbanken Fonder added most to Merck in Q3 2024, an estimated $115M increase.
- Handelsbanken Fonder's biggest Q3 2024 reduction was Edwards Lifesciences, cutting an estimated $53.5M.
- Handelsbanken Fonder fully exited TE Connectivity in Q3 2024, selling an estimated $26.7M.
- Handelsbanken Fonder's ten largest holdings make up 31% of its $25.3B portfolio in Q3 2024.
- Handelsbanken Fonder opened 18 new positions and closed 16 in Q3 2024.
- Handelsbanken Fonder's portfolio value rose 9.9% quarter-over-quarter to $25.3B.
Based on Handelsbanken Fonder's 13F filing for Q3 2024, filed 4 Oct 2024.